Five-year survival after stroke
Five-year survival of Grodnos inhabitants who had a stroke in2001 was investigated. Patients followed up prospectively up to5 years from the beginning of the disease; complete data after 5years were available for 853 of 875 patients (97.5%). Thecumulative five-year death risk, 63.0%, was 2.9 times g...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Research Center of Neurology
2017-02-01
|
| Series: | Анналы клинической и экспериментальной неврологии |
| Subjects: | |
| Online Access: | https://annaly-nevrologii.com/journal/pathID/article/viewFile/284/181 |
| Summary: | Five-year survival of Grodnos inhabitants who had a stroke in2001 was investigated. Patients followed up prospectively up to5 years from the beginning of the disease; complete data after 5years were available for 853 of 875 patients (97.5%). Thecumulative five-year death risk, 63.0%, was 2.9 times greaterthan for people of the same age and sex in Grodnos generalpopulation. The relative death risk was the highest in patientsyounger than 45 years (55.0) and decreased to 1.1 in patientsolder than 84 years. The significant distinction in 5-year survivalin patients with different types of stroke (subarachnoidhemorrhage 0.68; cerebral infarction 0.41; intracerebralhemorrhage 0.17; undetermined stroke 0.08) was mostlydetermined by the influence of acute stage rates and decreasedto small non-significant values in a group of 28-day survivors.Stroke (including the recurrent episodes) was the prevalentcause of death during the first year in 28-day survivors (67.0%), where as other cardiovascular diseases were the main causes ofdeath (62.0%) during the later period. The significant prognosticfactors of the 5-year death risk after stroke were age (hazardratio (HR) 1.04), stroke in anamnesis (HR 1.48), arterialhypertension (HR 0.76), and diabetes mellitus (1.26). In 28-day survivors the significant prognostic factors of the 5-yeardeath risk were age (HR 1.05), stroke in anamnesis (HR 1.62),diabetes mellitus (HR 1.46), atrial fibrillation (HR 1.34), andmyocardial infarction in anamnesis (HR 1.43). The obtaineddata shows strong necessity of secondary prevention, focusedboth on cerebral and heart vascular pools. |
|---|---|
| ISSN: | 2075-5473 2409-2533 |